You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HDAC inhibitor

Showing 26 - 50 of 7,551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in New York (Mocetinostat Induction Phase + Ipilimumab + Nivolumab, Mocetinostat Maintenance Phase + Ipilimumab +

Terminated
  • Melanoma
  • Mocetinostat Induction Phase + Ipilimumab + Nivolumab
  • Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
  • New York, New York
    New York University School of Medicine
May 19, 2020

Solid Tumor, Adult Trial in Houston (KA2507)

Completed
  • Solid Tumor, Adult
  • Houston, Texas
    M D Anderson
Aug 18, 2020

Follicular Lymphoma Trial in France, Spain, United States (Abexinostat)

Active, not recruiting
  • Follicular Lymphoma
  • Park Ridge, Illinois
  • +14 more
May 10, 2021

Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in United States (fimepinostat, Rituximab, venetoclax)

Completed
  • Lymphoma
  • +10 more
  • Los Angeles, California
  • +10 more
May 5, 2021

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023

Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

Recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 22, 2021

Myeloproliferative Diseases Trial in Bergamo, Pavia (ITF2357)

Completed
Has Results
  • Myeloproliferative Diseases
  • Bergamo, Italy
  • +1 more
Dec 2, 2019

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Huntington Disease Trial in Seoul (CKD-504, Placebo)

Unknown status
  • Huntington Disease
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 21, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Trial (Entinostat,

Withdrawn
  • Advanced Lymphoma
  • +16 more
  • (no location specified)
Sep 25, 2020

Solid Tumor Trial in Hamilton, Toronto (HDAC inhibitor SB939, immunoenzyme technique, immunohistochemistry staining method)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • HDAC inhibitor SB939
  • +7 more
  • Hamilton, Ontario, Canada
  • +1 more
Apr 6, 2020

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Prostate Cancer Trial in Canada (HDAC inhibitor SB939)

Completed
  • Prostate Cancer
  • HDAC inhibitor SB939
  • Calgary, Alberta, Canada
  • +6 more
Apr 6, 2020

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Locally Advanced NSCLC Trial in Tampa, Philadelphia, Charleston (vorinostat)

Completed
  • Locally Advanced Non-small Cell Lung Cancer
  • Tampa, Florida
  • +2 more
Nov 26, 2019

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Schizophrenia Trial in Richmond (Vorinostat Oral Capsule Group 1, Vorinostat Oral Capsule Group 2)

Withdrawn
  • Schizophrenia
  • Vorinostat Oral Capsule Group 1
  • Vorinostat Oral Capsule Group 2
  • Richmond, Virginia
    Virginia Commonwealth University
Feb 20, 2019

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

Recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Apr 8, 2022

Renal Cell Carcinoma, Soft Tissue Sarcoma, Metastatic Disease Trial in Richmond (AR-42, Pazopanib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 3, 2019

Lymphoma, Lymphoid Malignancies Trial in Tampa, New York (ACY-1215)

Completed
  • Lymphoma
  • Lymphoid Malignancies
  • Tampa, Florida
  • +1 more
Feb 6, 2020

Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Irvine, California
  • +1 more
Dec 14, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York

Completed
  • Acute Myeloid Leukemia
  • +7 more
  • Baltimore, Maryland
  • +2 more
Oct 17, 2019